Related Experiment Video
Updated: Jun 5, 2026
Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase
Srividya Venkitachalam1, Fu-Yu Chueh, King-Fu Leong
1Department of Microbiology and Immunology, H. M. Bligh Cancer Research Laboratories, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA.
Abstract:
Lymphocyte-specific protein tyrosine kinase (Lck) plays a key role in T cell signal transduction and is tightly regulated by phosphorylation and dephosphorylation. Lck can function as an oncoprotein when overexpressed or constantly activated by mutations. Our previous studies showed that Lck-induced cellular transformation could be suppressed by enforced expression of suppressor of cytokine signaling 1 (SOCS1), a SOCS family member involved in the negative feedback control of cytokine signaling. We observed attenuated Lck kinase activity in SOCS1-expressing cells, suggesting an important role of SOCS in regulating Lck functions. It remains largely unknown whether and how SOCS proteins interact with the oncogenic Lck kinase. Here, we report that among four SOCS family proteins, SOCS1, SOCS2, SOCS3 and CIS (cytokine-inducible SH2 domain containing protein), SOCS1 has the highest affinity in binding to the oncogenic Lck kinase. We identified the positive regulatory phosphotyrosine 394 residue in the kinase domain as the key interacting determinant in Lck. Additionally, the Lck kinase domain alone is sufficient to bind SOCS1. While the SH2 domain in SOCS1 is important in its association with the oncogenic Lck kinase, other functional domains may also contribute to overall binding affinity. These findings provide important mechanistic insights into the role of SOCS proteins as tumor suppressors in cells transformed by oncogenic protein tyrosine kinases.
Insights
Suppressor of cytokine signaling 1 (SOCS1) binds to oncogenic Lymphocyte-specific protein tyrosine kinase (Lck). This interaction, particularly at Lck's kinase domain, reveals how SOCS proteins may act as tumor suppressors.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Lymphocyte-specific protein tyrosine kinase (Lck) is crucial for T cell signaling and can act as an oncoprotein.
- Suppressor of cytokine signaling 1 (SOCS1) inhibits Lck-induced cellular transformation and kinase activity.
- The precise interaction mechanism between SOCS proteins and oncogenic Lck remains unclear.
Purpose of the Study:
- To investigate the interaction between SOCS family proteins and oncogenic Lck kinase.
- To identify the specific domains and residues involved in SOCS-Lck binding.
- To elucidate the role of SOCS proteins in regulating oncogenic Lck activity.
Main Methods:
- Co-immunoprecipitation assays to assess binding affinity between SOCS proteins and Lck.
- Site-directed mutagenesis to identify key interacting residues in Lck, specifically phosphotyrosine 394.
- Analysis of Lck kinase domain and SOCS1 SH2 domain contributions to binding.
Main Results:
- SOCS1 exhibits the highest binding affinity to oncogenic Lck among tested SOCS proteins (SOCS1, SOCS2, SOCS3, CIS).
- Phosphotyrosine 394 in the Lck kinase domain is a critical determinant for SOCS1 binding.
- The Lck kinase domain alone is sufficient for SOCS1 interaction, and the SOCS1 SH2 domain is important for this association.
Conclusions:
- SOCS1 directly binds to oncogenic Lck, primarily through Lck's kinase domain and phosphotyrosine 394.
- The SH2 domain of SOCS1 plays a significant role in the interaction with Lck.
- These findings offer mechanistic insights into SOCS proteins functioning as tumor suppressors against oncogenic protein tyrosine kinases.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:16TGF - β Signaling Pathway